Ilex Medical Ltd (ILX.TA)
ILA 6233.0
(-1.41%)
ILA 6233.0
(-1.41%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 231.86 Million ILS | -18.67% |
| 2022 | 285.1 Million ILS | -24.85% |
| 2021 | 379.38 Million ILS | 39.98% |
| 2020 | 271.02 Million ILS | 39.87% |
| 2019 | 193.76 Million ILS | 5.37% |
| 2018 | 183.88 Million ILS | 24.83% |
| 2017 | 147.31 Million ILS | 7.46% |
| 2016 | 137.08 Million ILS | -8.36% |
| 2015 | 149.59 Million ILS | 23.52% |
| 2014 | 121.11 Million ILS | -5.58% |
| 2013 | 128.27 Million ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 56.88 Million ILS | -12.2% |
| 2024 Q2 | 50.72 Million ILS | -10.82% |
| 2023 Q3 | 55.21 Million ILS | 3.75% |
| 2023 Q4 | 64.78 Million ILS | 17.33% |
| 2023 FY | 231.86 Million ILS | -18.67% |
| 2023 Q1 | 58.63 Million ILS | -14.74% |
| 2023 Q2 | 53.22 Million ILS | -9.23% |
| 2022 FY | 285.1 Million ILS | -24.85% |
| 2022 Q4 | 68.77 Million ILS | 8.96% |
| 2022 Q3 | 63.11 Million ILS | 25.55% |
| 2022 Q2 | 50.27 Million ILS | -51.16% |
| 2022 Q1 | 102.93 Million ILS | 21.82% |
| 2021 Q2 | 69.97 Million ILS | -15.96% |
| 2021 Q4 | 84.49 Million ILS | -40.34% |
| 2021 Q3 | 141.64 Million ILS | 102.42% |
| 2021 Q1 | 83.26 Million ILS | 37.38% |
| 2021 FY | 379.38 Million ILS | 39.98% |
| 2020 Q3 | 91.8 Million ILS | 36.25% |
| 2020 Q1 | 51.22 Million ILS | 7.39% |
| 2020 Q2 | 67.38 Million ILS | 31.55% |
| 2020 Q4 | 60.6 Million ILS | -33.98% |
| 2020 FY | 271.02 Million ILS | 39.87% |
| 2019 Q4 | 47.69 Million ILS | -6.33% |
| 2019 FY | 193.76 Million ILS | 5.37% |
| 2019 Q2 | 50.75 Million ILS | 14.35% |
| 2019 Q1 | 44.38 Million ILS | -17.0% |
| 2019 Q3 | 50.91 Million ILS | 0.32% |
| 2018 Q3 | 43.54 Million ILS | -6.54% |
| 2018 Q1 | 40.27 Million ILS | 12.4% |
| 2018 Q2 | 46.58 Million ILS | 15.67% |
| 2018 FY | 183.88 Million ILS | 24.83% |
| 2018 Q4 | 53.48 Million ILS | 22.83% |
| 2017 Q3 | 40.65 Million ILS | 14.93% |
| 2017 Q4 | 35.83 Million ILS | -11.87% |
| 2017 FY | 147.31 Million ILS | 7.46% |
| 2017 Q1 | 35.44 Million ILS | 8.13% |
| 2017 Q2 | 35.37 Million ILS | -0.21% |
| 2016 Q2 | 36.21 Million ILS | 16.39% |
| 2016 Q3 | 36.97 Million ILS | 2.09% |
| 2016 Q1 | 31.11 Million ILS | -19.63% |
| 2016 Q4 | 32.78 Million ILS | -11.34% |
| 2016 FY | 137.08 Million ILS | -8.36% |
| 2015 Q2 | 35.58 Million ILS | -7.2% |
| 2015 Q1 | 38.34 Million ILS | 26.98% |
| 2015 FY | 149.59 Million ILS | 23.52% |
| 2015 Q4 | 38.71 Million ILS | 4.8% |
| 2015 Q3 | 36.94 Million ILS | 3.82% |
| 2014 FY | 121.11 Million ILS | -5.58% |
| 2014 Q4 | 30.19 Million ILS | -6.5% |
| 2014 Q3 | 32.29 Million ILS | 3.9% |
| 2014 Q2 | 31.08 Million ILS | 12.88% |
| 2014 Q1 | 27.53 Million ILS | -24.97% |
| 2013 Q2 | 30.97 Million ILS | -4.25% |
| 2013 Q4 | 36.7 Million ILS | 29.88% |
| 2013 FY | 128.27 Million ILS | 0.0% |
| 2013 Q3 | 28.25 Million ILS | -8.76% |
| 2013 Q1 | 32.34 Million ILS | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|